Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (e)-4-(2-(2-(n-acetyl-n-(4-methoxybenzenesulfonyl)amino)stilbazole)) 1-oxide
1. 173529-46-9
2. Ivx-214
3. 94e9ur0rfr
4. Hmn214
5. (e)-4-(2-(n-((4-methoxyphenyl)sulfonyl)acetamido)styryl)pyridine 1-oxide
6. (e)-4-(2-(2-(n-acetyl-n-((p-methoxyphenyl)sulfonyl)amino)phenyl)ethenyl)pyridine 1-oxide
7. (e)-4-[2-[2-[n-acetyl-n-[(4-methoxyphenyl)sulfonyl]amino]phenyl]ethenyl]pyridine 1-oxide
8. Acetamide, N-((4-methoxyphenyl)sulfonyl)-n-(2-((1e)-2-(1-oxido-4-pyridinyl)ethenyl)phenyl)-
9. Hmn 214
10. N-(4-methoxyphenyl)sulfonyl-n-[2-[(e)-2-(1-oxidopyridin-1-ium-4-yl)ethenyl]phenyl]acetamide
11. Unii-94e9ur0rfr
12. (e)-4-[2-[2-[n-acetyl-n-[(p-methoxyphenyl)sulfonyl]amino]phenyl]ethenyl]pyridine 1-oxide
13. N-((4-methoxyphenyl)sulfonyl)-n-(2-((1e)-2-(1-oxido-4-pyridinyl)ethenyl)phenyl)-acetamide
14. N-[(4-methoxyphenyl)sulfonyl]-n-[2-[(1e)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]-acetamide
15. Acetamide, N-[(4-methoxyphenyl)sulfonyl]-n-[2-[(1e)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]-
16. Mls006011062
17. Schembl5173713
18. Schembl5173720
19. Chembl3991927
20. Chebi:91440
21. Bcpp000212
22. Dtxsid701025981
23. Zinc602090
24. Ex-a1158
25. Mfcd12756255
26. Nsc800767
27. S1485
28. Akos027270086
29. Bcp9000762
30. Ccg-268936
31. Cs-0202
32. Nsc-800767
33. (e)-4-(2-(2-(n-acetyl-n-(4-methoxybenzenesulfonyl)amino)stilbazole)) 1-oxide
34. Ac-32847
35. As-74407
36. Hy-12045
37. Smr004702854
38. Sw219842-1
39. A811525
40. Sr-03000003276
41. Sr-03000003276-1
42. Brd-k70511574-001-01-0
43. Q27271675
44. 4-[(1e)-2-{2-[n-(4-methoxybenzenesulfonyl)acetamido]phenyl}ethenyl]pyridin-1-ium-1-olate
45. Acetamide, N-((4-methoxyphenyl)sulfonyl)-n-(2-(2-(1-oxido-4-pyridinyl)ethenyl)phenyl)-, (e)-
46. N-(4-methoxyphenyl)sulfonyl-n-[2-[(e)-2-(1-oxidanidylpyridin-1-ium-4-yl)ethenyl]phenyl]ethanamide
47. N-(4-methoxyphenyl)sulfonyl-n-[2-[(e)-2-(1-oxido-4-pyridin-1-iumyl)ethenyl]phenyl]acetamide
| Molecular Weight | 424.5 g/mol |
|---|---|
| Molecular Formula | C22H20N2O5S |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 424.10929292 g/mol |
| Monoisotopic Mass | 424.10929292 g/mol |
| Topological Polar Surface Area | 97.5 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 689 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
24
PharmaCompass offers a list of N-4-Methoxybenzenesulfonyl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right N-4-Methoxybenzenesulfonyl manufacturer or N-4-Methoxybenzenesulfonyl supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred N-4-Methoxybenzenesulfonyl manufacturer or N-4-Methoxybenzenesulfonyl supplier.
PharmaCompass also assists you with knowing the N-4-Methoxybenzenesulfonyl API Price utilized in the formulation of products. N-4-Methoxybenzenesulfonyl API Price is not always fixed or binding as the N-4-Methoxybenzenesulfonyl Price is obtained through a variety of data sources. The N-4-Methoxybenzenesulfonyl Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A HMN 214 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of HMN 214, including repackagers and relabelers. The FDA regulates HMN 214 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. HMN 214 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A HMN 214 supplier is an individual or a company that provides HMN 214 active pharmaceutical ingredient (API) or HMN 214 finished formulations upon request. The HMN 214 suppliers may include HMN 214 API manufacturers, exporters, distributors and traders.
click here to find a list of HMN 214 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A HMN 214 DMF (Drug Master File) is a document detailing the whole manufacturing process of HMN 214 active pharmaceutical ingredient (API) in detail. Different forms of HMN 214 DMFs exist exist since differing nations have different regulations, such as HMN 214 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A HMN 214 DMF submitted to regulatory agencies in the US is known as a USDMF. HMN 214 USDMF includes data on HMN 214's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The HMN 214 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of HMN 214 suppliers with USDMF on PharmaCompass.
HMN 214 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of HMN 214 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right HMN 214 GMP manufacturer or HMN 214 GMP API supplier for your needs.
A HMN 214 CoA (Certificate of Analysis) is a formal document that attests to HMN 214's compliance with HMN 214 specifications and serves as a tool for batch-level quality control.
HMN 214 CoA mostly includes findings from lab analyses of a specific batch. For each HMN 214 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
HMN 214 may be tested according to a variety of international standards, such as European Pharmacopoeia (HMN 214 EP), HMN 214 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (HMN 214 USP).
